Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M UNGER

Showing results (551-560 of 604) with videos related to

Pageof 61
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2020
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105Dawn L Hershman, Joseph M Unger, Grace Clarke Hillyer, et al.
NPJ Breast Cancer|July 20, 2017
Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630Ronald K Potkul, Joseph M Unger, Robert B Livingston, et al.
Cancer|November 2, 2020
Caregiver engagement practices in National Cancer Institute Clinical Oncology Research Program settings: Implications for research to advance the fieldChandylen L Nightingale, Katherine R Sterba, Laurie E McLouth, et al.
Breast Cancer Research and Treatment|January 12, 2013
Supplement use during an intergroup clinical trial for breast cancer (S0221)Gary R Zirpoli, Patrick M Brennan, Chi-Chen Hong, et al.
Journal of the National Cancer Institute|March 17, 2018
Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP StudyGary R Zirpoli, Susan E McCann, Lara E Sucheston-Campbell, et al.
JCO Oncology Practice|April 2, 2021
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN)Joshua A Roth, Meghna S Trivedi, Stacy W Gray, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 26, 2012
A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation studyRonald B Postuma, Isabelle Arnulf, Birgit Hogl, et al.
Breast Cancer Research : BCR|November 30, 2018
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)Jennifer M Mongiovi, Gary R Zirpoli, Rikki Cannioto, et al.
Journal of the National Cancer Institute|May 17, 2019
The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized TrialYanhong Su, Jiajia Huang, Shusen Wang, et al.
Stem Cells Translational Medicine|September 20, 2025
Mesenchymal progenitor-derived proteoglycan 4 regulates the transdifferentiation of chondrocytes into osteoblasts during fracture healingNicoletta Ninkovic, Jessica May Corpuz, Alana Stahl, et al.
Pageof 61

Showing results (551-560 of 604) with videos related to

Sort By:
Pageof 61
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2020
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105Dawn L Hershman, Joseph M Unger, Grace Clarke Hillyer, et al.
NPJ Breast Cancer|July 20, 2017
Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630Ronald K Potkul, Joseph M Unger, Robert B Livingston, et al.
Cancer|November 2, 2020
Caregiver engagement practices in National Cancer Institute Clinical Oncology Research Program settings: Implications for research to advance the fieldChandylen L Nightingale, Katherine R Sterba, Laurie E McLouth, et al.
Breast Cancer Research and Treatment|January 12, 2013
Supplement use during an intergroup clinical trial for breast cancer (S0221)Gary R Zirpoli, Patrick M Brennan, Chi-Chen Hong, et al.
Journal of the National Cancer Institute|March 17, 2018
Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP StudyGary R Zirpoli, Susan E McCann, Lara E Sucheston-Campbell, et al.
JCO Oncology Practice|April 2, 2021
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN)Joshua A Roth, Meghna S Trivedi, Stacy W Gray, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 26, 2012
A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation studyRonald B Postuma, Isabelle Arnulf, Birgit Hogl, et al.
Breast Cancer Research : BCR|November 30, 2018
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)Jennifer M Mongiovi, Gary R Zirpoli, Rikki Cannioto, et al.
Journal of the National Cancer Institute|May 17, 2019
The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized TrialYanhong Su, Jiajia Huang, Shusen Wang, et al.
Stem Cells Translational Medicine|September 20, 2025
Mesenchymal progenitor-derived proteoglycan 4 regulates the transdifferentiation of chondrocytes into osteoblasts during fracture healingNicoletta Ninkovic, Jessica May Corpuz, Alana Stahl, et al.
Pageof 61